HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1501	21784 Herrera FE, Chesi A, Paleologou KE, Schmid A, Munoz A, et al. Inhibition of alpha-Synuclein Fibrillization by Dopamine Is Mediated by Interactions with Five C-Terminal Residues and with E83 in the NAC Region PLOS ONE. 2008 OCT 14; 3 (10): Art. No. e3394	8	10	36	69
1502	21791 Rodriguez-Navarro JA, Gomez A, Rodal I, Perucho J, Martinez A, et al. Parkin deletion causes cerebral and systemic amyloidosis in human mutated tau over-expressing mice HUMAN MOLECULAR GENETICS. 2008 OCT 15; 17 (20): 3128-3143	2	6	36	87
1503	21871 Aliev G, Obrenovich ME, Reddy VP, Shenk JC, Moreira PI, et al. Antioxidant Therapy in Alzheimer's Disease: Theory and Practice MINI-REVIEWS IN MEDICINAL CHEMISTRY. 2008 NOV; 8 (13): 1395-1406	0	14	36	183
1504	21894 Saavedra A, Baltazar G, Duarte EP Driving GDNF expression: The green and the red traffic lights PROGRESS IN NEUROBIOLOGY. 2008 NOV; 86 (3): 186-215	1	10	36	453
1505	21970 Drago D, Bolognin S, Zatta P Role of Metal Ions in the A beta Oligomerization in Alzheimer's Disease and in Other Neurological Disorders CURRENT ALZHEIMER RESEARCH. 2008 DEC; 5 (6): 500-507	5	13	36	118
1506	22026 Fato R, Bergamini C, Leoni S, Strocchi P, Lenaz G Generation of Reactive Oxygen Species by Mitochondrial Complex I: Implications in Neurodegeneration NEUROCHEMICAL RESEARCH. 2008 DEC; 33 (12): 2487-2501	3	14	36	200
1507	22071 Navarro R, Guerrero R, Gallego E, Avila J, Luquin R, et al. Motor alterations are reduced in mice lacking the PARK2 gene in the presence of a human FTDP-17 mutant form of four-repeat tau JOURNAL OF THE NEUROLOGICAL SCIENCES. 2008 DEC 15; 275 (1-2): 139-144	0	0	36	59
1508	22102 Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis AMYOTROPHIC LATERAL SCLEROSIS. 2009; 10 (3): 131-146	12	24	36	145
1509	22474 Ikeda M, Kawarabayashi T, Harigaya Y, Sasaki A, Yamada S, et al. Motor impairment and aberrant production of neurochemicals in human alpha-synuclein A30P+A53T transgenic mice with alpha-synuclein pathology BRAIN RESEARCH. 2009 JAN 23; 1250: 232-241	3	4	36	53
1510	22492 Arai T, Mackenzie IRA, Hasegawa M, Nonoka T, Niizato K, et al. Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies ACTA NEUROPATHOLOGICA. 2009 FEB; 117 (2): 125-136	33	33	36	43
#	Date / Author / Journal	LCS	GCS	LCR	CR
1511	22686 Hanes J, Zilka N, Bartkova M, Caletkova M, Dobrota D, et al. Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies JOURNAL OF NEUROCHEMISTRY. 2009 MAR; 108 (5): 1167-1176	2	4	36	56
1512	22849 Revuelta GJ, Lippa CF FOR DEBATE: DEMENTIA WITH LEWY BODIES AND PARKINSON'S DISEASE DEMENTIA: ARE THEY THE SAME ENTITY? Introduction INTERNATIONAL PSYCHOGERIATRICS. 2009 APR; 21 (2): 212-224	0	0	36	64
1513	22910 Jaeger PA, Wyss-Coray T All-you-can-eat: autophagy in neurodegeneration and neuroprotection MOLECULAR NEURODEGENERATION. 2009 APR 6; 4: Art. No. 16	6	24	36	277
1514	23104 Qiao LY, Zhang JH Inhibition of lysosomal functions reduces proteasomal activity NEUROSCIENCE LETTERS. 2009 MAY 29; 456 (1): 15-19	2	4	36	66
1515	23220 Bayir H, Kapralov AA, Jiang JF, Huang ZT, Tyurina YY, et al. Peroxidase Mechanism of Lipid-dependent Cross-linking of Synuclein with Cytochrome c PROTECTION AGAINST APOPTOSIS VERSUS DELAYED OXIDATIVE STRESS IN PARKINSON DISEASE JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 JUN 5; 284 (23): 15951-15969	3	7	36	73
1516	23431 Daher JPL, Ying MY, Banerjee R, McDonald RS, Hahn MD, et al. Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alpha Syn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons MOLECULAR NEURODEGENERATION. 2009 JUL 24; 4: Art. No. 34	6	6	36	48
1517	23655 Lillo P, Hodges JR Frontotemporal dementia and motor neurone disease: Overlapping clinic- pathological disorders JOURNAL OF CLINICAL NEUROSCIENCE. 2009 SEP; 16 (9): 1131-1135	5	6	36	83
1518	23698 Chu YP, Dodiya H, Aebischer P, Olanow CW, Kordower JH Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions NEUROBIOLOGY OF DISEASE. 2009 SEP; 35 (3): 385-398	11	15	36	62
1519	24064 Kahle PJ, Waak J, Gasser T DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders FREE RADICAL BIOLOGY AND MEDICINE. 2009 NOV 15; 47 (10): 1354-1361	6	16	36	124
1520	24241 LaPointe NE, Horowitz PM, Guillozet-Bongaarts AL, Silva A, Andreadis A, et al. Tau 6D and 6P Isoforms Inhibit Polymerization of Full-Length Tau in Vitro BIOCHEMISTRY. 2009 DEC 29; 48 (51): 12290-12297	0	0	36	48
#	Date / Author / Journal	LCS	GCS	LCR	CR
1521	24460 Shorter J Emergence and natural selection of drug-resistant prions MOLECULAR BIOSYSTEMS. 2010; 6 (7): 1115-1130	1	1	36	250
1522	24710 van Ham TJ, Esposito A, Kumita JR, Hsu STD, Schierle GSK, et al. Towards Multiparametric Fluorescent Imaging of Amyloid Formation: Studies of a YFP Model of alpha-Synuclein Aggregation JOURNAL OF MOLECULAR BIOLOGY. 2010 JAN 22; 395 (3): 627-642	1	1	36	71
1523	24900 Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, et al. Genome-Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease ANNALS OF HUMAN GENETICS. 2010 MAR; 74: 97-109	11	23	36	101
1524	24939 Su LHJ, Auluck PK, Outeiro TF, Yeger-Lotem E, Kritzer JA, et al. Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models DISEASE MODELS & MECHANISMS. 2010 MAR-APR; 3 (3-4): 194-208	3	3	36	69
1525	25086 Kraemer BC, Schuck T, Wheeler JM, Robinson LC, Trojanowski JQ, et al. Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis ACTA NEUROPATHOLOGICA. 2010 APR; 119 (4): 409-419	13	13	36	52
1526	25115 Zhong SC, Luo X, Chen XS, Cai QY, Liu J, et al. Expression and Subcellular Location of Alpha-Synuclein During Mouse- Embryonic Development CELLULAR AND MOLECULAR NEUROBIOLOGY. 2010 APR; 30 (3): 469-482	1	1	36	55
1527	25220 Crews L, Masliah E Molecular mechanisms of neurodegeneration in Alzheimer's disease HUMAN MOLECULAR GENETICS. 2010 APR 15; 19: R12-R20	0	2	36	167
1528	25304 Avila J, Wandosell F, Hernandez F Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors EXPERT REVIEW OF NEUROTHERAPEUTICS. 2010 MAY; 10 (5): 703-710	1	1	36	103
1529	25463 Caudle WM, Bammler TK, Lin Y, Pan S, Zhang J Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease EXPERT REVIEW OF NEUROTHERAPEUTICS. 2010 JUN; 10 (6): 925-942	0	1	36	136
1530	25658 Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, et al. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives NATURE REVIEWS DRUG DISCOVERY. 2010 JUL; 9 (7): 560-574	7	11	36	139
#	Date / Author / Journal	LCS	GCS	LCR	CR
1531	25760 Ando K, Leroy K, Heraud C, Kabova A, Yilmaz Z, et al. Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model BIOCHEMICAL SOCIETY TRANSACTIONS. 2010 AUG; 38: 1001-1005	1	1	36	48
1532	25799 Uversky VN Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D-2 concept EXPERT REVIEW OF PROTEOMICS. 2010 AUG; 7 (4): 543-564	0	1	36	220
1533	25914 Dawson HN, Cantillana V, Jansen M, Wang H, Vitek MP, et al. LOSS OF TAU ELICITS AXONAL DEGENERATION IN A MOUSE MODEL OF ALZHEIMER'S DISEASE NEUROSCIENCE. 2010 AUG 11; 169 (1): 516-531	2	4	36	87
1534	25954 Hu WT, Chen-Plotkin A, Arnold SE, Grossman M, Clark CM, et al. Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease ACTA NEUROPATHOLOGICA. 2010 SEP; 120 (3): 385-399	2	2	36	81
1535	26322 Cowan CM, Bossing T, Page A, Shepherd D, Mudher A Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo ACTA NEUROPATHOLOGICA. 2010 NOV; 120 (5): 593-604	1	2	36	51
1536	26644 Hinault MP, Cuendet AFH, Mattoo RUH, Mensi M, Dietler G, et al. Stable alpha-Synuclein Oligomers Strongly Inhibit Chaperone Activity of the Hsp70 System by Weak Interactions with J-domain Co-chaperones JOURNAL OF BIOLOGICAL CHEMISTRY. 2010 DEC 3; 285 (49): 38173-38182	0	0	36	62
1537	1347 YETERIAN EH, PANDYA DN THALAMIC CONNECTIONS OF THE CORTEX OF THE SUPERIOR TEMPORAL SULCUS IN THE RHESUS-MONKEY JOURNAL OF COMPARATIVE NEUROLOGY. 1989 APR 1; 282 (1): 80-97	13	53	35	114
1538	1849 FLIEGNER KH, LIEM RKH CELLULAR AND MOLECULAR-BIOLOGY OF NEURONAL INTERMEDIATE FILAMENTS INTERNATIONAL REVIEW OF CYTOLOGY-A SURVEY OF CELL BIOLOGY. 1991; 131: 109-167	35	85	35	261
1539	3685 DREWES G, TRINCZEK B, ILLENBERGER S, BIERNAT J, SCHMITTULMS G, et al. MICROTUBULE-ASSOCIATED PROTEIN MICROTUBULE AFFINITY-REGULATING KINASE (P110(MARK)) - A NOVEL PROTEIN-KINASE THAT REGULATES TAU-MICROTUBULE INTERACTIONS AND DYNAMIC INSTABILITY BY PHOSPHORYLATION AT THE ALZHEIMER-SPECIFIC SITE SERINE-262 JOURNAL OF BIOLOGICAL CHEMISTRY. 1995 MAR 31; 270 (13): 7679-7688	137	185	35	70
1540	4132 Goedert M, Spillantini MG, Hasegawa M, Jakes R, Crowther RA, et al. Molecular dissection of the neurofibrillary lesions of Alzheimer's disease COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY. 1996; 61: 565-573	15	18	35	57
#	Date / Author / Journal	LCS	GCS	LCR	CR
1541	4258 Shea TB, Fischer I Phosphatase inhibition in human neuroblastoma cells alters tau antigenicity and renders it incompetent to associate with exogenous microtubules FEBS LETTERS. 1996 FEB 12; 380 (1-2): 63-67	17	21	35	58
1542	4493 Shea TB Induction of lysosomal abnormalities and tau hyperphosphorylation in human neuroblastoma cells by colchicine and okadaic acid: Evidence that microtubule disruption contributes to Alzheimer neurodegeneration NEUROSCIENCE RESEARCH COMMUNICATIONS. 1996 JUL-AUG; 19 (1): 27-36	3	5	35	67
1543	5180 Hoffmann R, Lee VMY, Leight S, Varga I, Otvos L Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites BIOCHEMISTRY. 1997 JUL 1; 36 (26): 8114-8124	100	119	35	65
1544	5218 Sergeant N, David JP, Goedert M, Jakes R, Vermersch P, et al. Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: Demonstration of an additional 74-kDa component and age-related biochemical modifications JOURNAL OF NEUROCHEMISTRY. 1997 AUG; 69 (2): 834-844	36	48	35	65
1545	6058 Simic G, Gnjidic M, Kostovic I Cytoskeletal changes as an alternative view on pathogenesis of Alzheimer's disease PERIODICUM BIOLOGORUM. 1998 JUN; 100 (2): 165-173	1	2	35	96
1546	6479 Gomez-Tortosa E, Ingraham AO, Irizarry MC, Hyman BT Dementia with Lewy bodies JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 1998 NOV; 46 (11): 1449-1458	20	32	35	154
1547	6616 Iqbal K, Alonso AD, Gondal JA, Gong CX, Haque N, et al. Inhibition of neurofibrillary degeneration: A rational and promising therapeutic target ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 269-280	0	0	35	68
1548	7754 Jellinger KA, Stadelmann C Mechanisms of cell death in neurodegenerative disorders ADVANCES IN DEMENTIA RESEARCH. 2000; : 95-114	0	0	35	123
1549	7766 Jellinger KA, Stadelmann C The enigma of cell death in neurodegenerative disorders ADVANCES IN RESEARCH ON NEURODEGENERATION, VOL 8. 2000; 8: 21-36	0	0	35	112
1550	7834 Jellinger KA, Stadelmann C Mechanisms of cell death in neurodegenerative disorders JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (59): 95-114	0	51	35	123
#	Date / Author / Journal	LCS	GCS	LCR	CR
1551	8333 Shibata N, Hirano A, Yamamoto T, Kato Y, Kobayashi M Superoxide dismutase-1 mutation-related neurotoxicity in familial amyotrophic lateral sclerosis AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS. 2000 JUN; 1 (3): 143-161	6	26	35	238
1552	8506 Iwai A Properties of NACP/alpha-synuclein and its role in Alzheimer's disease BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2000 JUL 26; 1502 (1): 95-109	34	40	35	91
1553	8670 Kahle PJ, Neumann M, Ozmen L, Muller V, Jacobsen H, et al. Subcellular localization of wild-type and Parkinson's disease- associated mutant alpha-synuclein in human and transgenic mouse brain JOURNAL OF NEUROSCIENCE. 2000 SEP 1; 20 (17): 6365-6373	226	244	35	56
1554	8802 Goedert M, Satumtira S, Jakes R, Smith MJ, Kamibayashi C, et al. Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutations JOURNAL OF NEUROCHEMISTRY. 2000 NOV; 75 (5): 2155-2162	39	47	35	43
1555	9045 Masters CL, Beyreuther K The natural history of Alzheimer's disease: Minding the gaps in understanding the mechanisms of neurodegeneration NEURODEGENERATIVE DISORDERS: LOSS OF FUNCTION THROUGH GAIN OF FUNCTION. 2001; : 1-21	1	1	35	193
1556	9048 Price DL, Wong PC, Markowska AL, Thinakaran G, Lee MK, et al. The value of transgenic models for the study of neurodegenerative diseases NEURODEGENERATIVE DISORDERS: LOSS OF FUNCTION THROUGH GAIN OF FUNCTION. 2001; : 67-86	0	0	35	162
1557	9437 Selkoe DJ Alzheimer's disease: Genes, proteins, and therapy PHYSIOLOGICAL REVIEWS. 2001 APR; 81 (2): 741-766	416	2136	35	216
1558	10014 Schmidt ML, Zhukareva V, Perl DP, Sheridan SK, Schuck T, et al. Spinal cord neurofibrillary pathology in Alzheimer disease and Guam parkinsonism-dementia complex JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2001 NOV; 60 (11): 1075-1086	16	16	35	50
1559	10032 Berry RW, Quinn B, Johnson N, Cochran EJ, Ghoshal N, et al. Pathological glial tau accumulations in neurodegenerative disease: review and case report NEUROCHEMISTRY INTERNATIONAL. 2001 NOV-DEC; 39 (5-6): 469-479	18	22	35	68
1560	10040 Chung KKK, Dawson VL, Dawson TM The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders TRENDS IN NEUROSCIENCES. 2001 NOV; 24 (11): S7-S14	56	115	35	71
#	Date / Author / Journal	LCS	GCS	LCR	CR
1561	10200 Jellinger KA, Stadelmann C Problems of programmed cell death in neurodegenerative disorders AGING: MORPHOLOGICAL, BIOCHEMICAL, MOLECULAR AND SOCIAL ASPECTS. 2002; 27: 123-144	0	0	35	113
1562	10455 Mori F, Inenaga C, Yoshimoto M, Umezu H, Tanaka R, et al. alpha-synuclein immunoreactivity in normal and neoplastic Schwann cells ACTA NEUROPATHOLOGICA. 2002 FEB; 103 (2): 145-151	16	17	35	47
1563	10511 Zhou WB, Schaack J, Zawada WM, Freed CR Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture BRAIN RESEARCH. 2002 FEB 1; 926 (1-2): 42-50	68	82	35	44
1564	10804 Kruger R, Eberhardt O, Riess O, Schulz JB Parkinson's disease: one biochemical pathway to fit all genes? TRENDS IN MOLECULAR MEDICINE. 2002 MAY; 8 (5): 236-240	25	47	35	61
1565	11019 Teunissen CE, de Vente J, Steinbusch HWM, De Bruijn C Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid NEUROBIOLOGY OF AGING. 2002 JUL-AUG; 23 (4): 485-508	32	91	35	315
1566	11059 Meade CA, Deng YP, Fusco FR, Del Mar N, Hersch S, et al. Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice JOURNAL OF COMPARATIVE NEUROLOGY. 2002 JUL 29; 449 (3): 241-269	3	46	35	146
1567	11720 Herrmann H, Hesse M, Reichenzeller M, Aebi U, Magin TM Functional complexity of intermediate filament cytoskeletons: From structure to assembly to gene ablation INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 223. 2003; 223: 83-+	3	104	35	439
1568	11792 Gasser T Overview of the genetics of parkinsonism PARKINSON'S DISEASE. 2003; 91: 143-152	8	19	35	99
1569	11964 Wirths O, Bayer TA alpha-synuclein, A beta and Alzheimer's disease PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2003 FEB; 27 (1): 103-108	13	14	35	60
1570	12262 Vila M, Przedborski S Targeting programmed cell death in neurodegenerative diseases NATURE REVIEWS NEUROSCIENCE. 2003 MAY; 4 (5): 365-375	40	153	35	163
#	Date / Author / Journal	LCS	GCS	LCR	CR
1571	12270 Wong AHC, Van Tol HHM Schizophrenia: from phenomenology to neurobiology NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2003 MAY; 27 (3): 269-306	6	76	35	527
1572	12597 Blennow K, Vanmechelen E CSF markers for pathogenic processes in Alzheimer's disease: diagnostic implications and use in clinical neurochemistry BRAIN RESEARCH BULLETIN. 2003 AUG 15; 61 (3): 235-242	20	36	35	57
1573	12729 Hogg M, Grujic ZM, Baker M, Demirci S, Guillozet AL, et al. The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy ACTA NEUROPATHOLOGICA. 2003 OCT; 106 (4): 323-336	30	31	35	59
1574	12736 Morris JC Dementia update 2003 ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 OCT-DEC; 17 (4): 245-258	5	14	35	170
1575	13214 Tatebayashi Y, Sato S, Akagi T, Chui DH, Miyasaka T, et al. Deregulation of GSK-3 beta and JNK in a mouse model of tauopathy: A kinase combination that induces Alzheimer-type tau hyperphosphorylation MOLECULAR NEUROBIOLOGY OF ALZHEIMER DISEASE AND RELATED DISORDERS. 2004; : 62-70	0	0	35	49
1576	13622 Planel E, Miyasaka T, Launey T, Chui DH, Tanemura K, et al. Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: Implications for Alzheimer's disease JOURNAL OF NEUROSCIENCE. 2004 MAR 10; 24 (10): 2401-2411	36	65	35	71
1577	13650 Lindersson E, Beedholm R, Hojrup P, Moos T, Gai WP, et al. Proteasomal inhibition by alpha-synuclein filaments and oligomers JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 MAR 26; 279 (13): 12924-12934	93	110	35	58
1578	13851 Kim SH, Seo JH, Suh YH alpha-Syrtuclein, Parkinson's disease, and Alzheimer's disease PARKINSONISM & RELATED DISORDERS. 2004 MAY; 10: S9-S13	11	14	35	75
1579	13978 Agorogiannis EI, Agorogiannis GI, Papadimitriou A, Hadjigeorgiou GM Protein misfolding in neurodegenerative diseases NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2004 JUN; 30 (3): 215-224	18	48	35	80
1580	14630 Lovell MA, Xiong SL, Xie CS, Davies P, Markesbery WR Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3 JOURNAL OF ALZHEIMERS DISEASE. 2004 DEC; 6 (6): 659-671	13	28	35	67
#	Date / Author / Journal	LCS	GCS	LCR	CR
1581	14644 Longhi L, Watson DJ, Saatman KE, Thompson HJ, Zhang C, et al. Ex vivo gene therapy using targeted engraftment of NGF-expressing human NT2N neurons attenuates cognitive deficits following traumatic brain injury in mice JOURNAL OF NEUROTRAUMA. 2004 DEC; 21 (12): 1723-1736	35	35	35	79
1582	14736 Levy YS, Gilgun-Sherki Y, Melamed E, Offen D Therapeutic potential of neurotrophic factors in neurodegenerative diseases BIODRUGS. 2005; 19 (2): 97-127	5	22	35	347
1583	14874 Iqbal K, Grundke-Iqbal I Metabolic/signal transduction hypothesis of Alzheime's disease and other tauopathies ACTA NEUROPATHOLOGICA. 2005 JAN; 109 (1): 25-31	25	35	35	62
1584	15030 Zhang XP, Chen YM, Jenkins LW, Kochanek PM, Clark RSB Bench-to-bedside review: Apoptosis/programmed cell death triggered by traumatic brain injury CRITICAL CARE. 2005 FEB; 9 (1): 66-75	13	36	35	123
1585	15100 Terwel D, Lasrado R, Snauwaert J, Vandeweert E, Van Haesendonck C, et al. Changed conformation of mutant tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of tau-4R/2N transgenic mice JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 FEB 4; 280 (5): 3963-3973	43	51	35	59
1586	15157 Yancopoulou D, Xuereb JH, Crowther RA, Hodges JR, Spillantini MG Tau and alpha-synuclein inclusions in a case of familial frontotemporal dementia and progressive aphasia JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2005 MAR; 64 (3): 245-253	7	7	35	44
1587	15879 Blennow K CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2005 SEP; 5 (5): 661-672	18	40	35	99
1588	15997 Liu F, Grundke-Iqbal I, Iqbal K, Gong CX Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation EUROPEAN JOURNAL OF NEUROSCIENCE. 2005 OCT; 22 (8): 1942-1950	73	106	35	48
1589	16030 Gouras GK, Almeida CG, Takahashi RH Intraneuronal A beta accumulation and origin of plaques in Alzheimer's disease NEUROBIOLOGY OF AGING. 2005 OCT; 26 (9): 1235-1244	29	116	35	90
1590	16059 Higuchi M, Zhang B, Forman MS, Yoshiyama Y, Trojanowski JQ, et al. Axonal degeneration induced by targeted expression of mutant human tau in oligodendrocytes of transgenic mice that model glial tauopathies JOURNAL OF NEUROSCIENCE. 2005 OCT 12; 25 (41): 9434-9443	27	27	35	61
#	Date / Author / Journal	LCS	GCS	LCR	CR
1591	16121 Bronner IF, ter Meulen BC, Azmani A, Severijnen LA, Willemsen R, et al. Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology BRAIN. 2005 NOV; 128: 2645-2653	17	18	35	44
1592	16211 Yagi H, Kusaka E, Hongo K, Mizobata T, Kawata Y Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins - Implications for the mechanism of transmissible conformational diseases JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 NOV 18; 280 (46): 38609-38616	7	21	35	70
1593	16374 Ved R, Saha S, Westlund B, Perier C, Burnam L, et al. Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 DEC 30; 280 (52): 42655-42668	33	78	35	66
1594	16377 Ulmer TS, Bax A Comparison of structure and dynamics of micelle-bound human alpha- synuclein and Parkinson disease variants JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 DEC 30; 280 (52): 43179-43187	28	42	35	78
1595	16498 Avila J, Santa-Maria I, Perez M, Hernandez F, Moreno F Tau phosphorylation, aggregation, and cell toxicity JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 74539	0	9	35	57
1596	16800 Jeganathan S, von Bergen M, Brutlach H, Steinhoff HJ, Mandelkow E Global hairpin folding of tau in solution BIOCHEMISTRY. 2006 FEB 21; 45 (7): 2283-2293	21	40	35	67
1597	17061 Cripps D, Thomas SN, Jeng Y, Yang F, Davies P, et al. Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation JOURNAL OF BIOLOGICAL CHEMISTRY. 2006 APR 21; 281 (16): 10825-10838	25	40	35	57
1598	17183 Schapira AHV Etiology of Parkinson's disease NEUROLOGY. 2006 MAY 23; 66 (10): S10-S23	16	56	35	138
1599	17341 Nagatsu T, Sawada M Cellular and molecular mechanisms of Parkinson's disease: Neurotoxins, causative genes, and inflammatory cytokines CELLULAR AND MOLECULAR NEUROBIOLOGY. 2006 JUL-AUG; 26 (4-6): 781-802	7	29	35	127
1600	17431 Chau KWK, Chan WY, Shaw PC, Chan HYE Biochemical investigation of Tau protein phosphorylation status and its solubility properties in Drosophila BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2006 JUL 21; 346 (1): 150-159	8	10	35	46

Date / Author / Journal

LCS

GCS

LCR

1501

21784 Herrera FE, Chesi A, Paleologou KE, Schmid A, Munoz A, et al.

Inhibition of alpha-Synuclein Fibrillization by Dopamine Is Mediated by Interactions with Five C-Terminal Residues and with E83 in the NAC Region

PLOS ONE. 2008 OCT 14; 3 (10): Art. No. e3394

1502

21791 Rodriguez-Navarro JA, Gomez A, Rodal I, Perucho J, Martinez A, et al.

Parkin deletion causes cerebral and systemic amyloidosis in human mutated tau over-expressing mice

HUMAN MOLECULAR GENETICS. 2008 OCT 15; 17 (20): 3128-3143

1503

21871 Aliev G, Obrenovich ME, Reddy VP, Shenk JC, Moreira PI, et al.

Antioxidant Therapy in Alzheimer's Disease: Theory and Practice

MINI-REVIEWS IN MEDICINAL CHEMISTRY. 2008 NOV; 8 (13): 1395-1406

183

1504

21894 Saavedra A, Baltazar G, Duarte EP

Driving GDNF expression: The green and the red traffic lights

PROGRESS IN NEUROBIOLOGY. 2008 NOV; 86 (3): 186-215

453

1505

21970 Drago D, Bolognin S, Zatta P

Role of Metal Ions in the A beta Oligomerization in Alzheimer's Disease and in Other Neurological Disorders

CURRENT ALZHEIMER RESEARCH. 2008 DEC; 5 (6): 500-507

118

1506

22026 Fato R, Bergamini C, Leoni S, Strocchi P, Lenaz G

Generation of Reactive Oxygen Species by Mitochondrial Complex I: Implications in Neurodegeneration

NEUROCHEMICAL RESEARCH. 2008 DEC; 33 (12): 2487-2501

200

1507

22071 Navarro R, Guerrero R, Gallego E, Avila J, Luquin R, et al.

Motor alterations are reduced in mice lacking the PARK2 gene in the presence of a human FTDP-17 mutant form of four-repeat tau

JOURNAL OF THE NEUROLOGICAL SCIENCES. 2008 DEC 15; 275 (1-2): 139-144

1508

22102 Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, et al.

Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis

AMYOTROPHIC LATERAL SCLEROSIS. 2009; 10 (3): 131-146

145

1509

22474 Ikeda M, Kawarabayashi T, Harigaya Y, Sasaki A, Yamada S, et al.

Motor impairment and aberrant production of neurochemicals in human alpha-synuclein A30P+A53T transgenic mice with alpha-synuclein pathology

BRAIN RESEARCH. 2009 JAN 23; 1250: 232-241

1510

22492 Arai T, Mackenzie IRA, Hasegawa M, Nonoka T, Niizato K, et al.

Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies

ACTA NEUROPATHOLOGICA. 2009 FEB; 117 (2): 125-136

Date / Author / Journal

LCS

GCS

LCR

1511

22686 Hanes J, Zilka N, Bartkova M, Caletkova M, Dobrota D, et al.

Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies

JOURNAL OF NEUROCHEMISTRY. 2009 MAR; 108 (5): 1167-1176

1512

22849 Revuelta GJ, Lippa CF

FOR DEBATE: DEMENTIA WITH LEWY BODIES AND PARKINSON'S DISEASE DEMENTIA: ARE THEY THE SAME ENTITY? Introduction

INTERNATIONAL PSYCHOGERIATRICS. 2009 APR; 21 (2): 212-224

1513

22910 Jaeger PA, Wyss-Coray T

All-you-can-eat: autophagy in neurodegeneration and neuroprotection

MOLECULAR NEURODEGENERATION. 2009 APR 6; 4: Art. No. 16

277

1514

23104 Qiao LY, Zhang JH

Inhibition of lysosomal functions reduces proteasomal activity

NEUROSCIENCE LETTERS. 2009 MAY 29; 456 (1): 15-19

1515

23220 Bayir H, Kapralov AA, Jiang JF, Huang ZT, Tyurina YY, et al.

Peroxidase Mechanism of Lipid-dependent Cross-linking of Synuclein with Cytochrome c PROTECTION AGAINST APOPTOSIS VERSUS DELAYED OXIDATIVE STRESS IN PARKINSON DISEASE

JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 JUN 5; 284 (23): 15951-15969

1516

23431 Daher JPL, Ying MY, Banerjee R, McDonald RS, Hahn MD, et al.

Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alpha Syn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons

MOLECULAR NEURODEGENERATION. 2009 JUL 24; 4: Art. No. 34

1517

23655 Lillo P, Hodges JR

Frontotemporal dementia and motor neurone disease: Overlapping clinic- pathological disorders

JOURNAL OF CLINICAL NEUROSCIENCE. 2009 SEP; 16 (9): 1131-1135

1518

23698 Chu YP, Dodiya H, Aebischer P, Olanow CW, Kordower JH

Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions

NEUROBIOLOGY OF DISEASE. 2009 SEP; 35 (3): 385-398

1519

24064 Kahle PJ, Waak J, Gasser T

DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders

FREE RADICAL BIOLOGY AND MEDICINE. 2009 NOV 15; 47 (10): 1354-1361

124

1520

24241 LaPointe NE, Horowitz PM, Guillozet-Bongaarts AL, Silva A, Andreadis A, et al.

Tau 6D and 6P Isoforms Inhibit Polymerization of Full-Length Tau in Vitro

BIOCHEMISTRY. 2009 DEC 29; 48 (51): 12290-12297

Date / Author / Journal

1521

Emergence and natural selection of drug-resistant prions

MOLECULAR BIOSYSTEMS. 2010; 6 (7): 1115-1130

250

1522

24710 van Ham TJ, Esposito A, Kumita JR, Hsu STD, Schierle GSK, et al.

Towards Multiparametric Fluorescent Imaging of Amyloid Formation: Studies of a YFP Model of alpha-Synuclein Aggregation

JOURNAL OF MOLECULAR BIOLOGY. 2010 JAN 22; 395 (3): 627-642

1523

24900 Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, et al.

Genome-Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease

ANNALS OF HUMAN GENETICS. 2010 MAR; 74: 97-109

101

1524

24939 Su LHJ, Auluck PK, Outeiro TF, Yeger-Lotem E, Kritzer JA, et al.

Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models

DISEASE MODELS & MECHANISMS. 2010 MAR-APR; 3 (3-4): 194-208

1525

25086 Kraemer BC, Schuck T, Wheeler JM, Robinson LC, Trojanowski JQ, et al.

Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis

ACTA NEUROPATHOLOGICA. 2010 APR; 119 (4): 409-419

1526

25115 Zhong SC, Luo X, Chen XS, Cai QY, Liu J, et al.

Expression and Subcellular Location of Alpha-Synuclein During Mouse- Embryonic Development

CELLULAR AND MOLECULAR NEUROBIOLOGY. 2010 APR; 30 (3): 469-482

1527

25220 Crews L, Masliah E

Molecular mechanisms of neurodegeneration in Alzheimer's disease

HUMAN MOLECULAR GENETICS. 2010 APR 15; 19: R12-R20

167

1528

25304 Avila J, Wandosell F, Hernandez F

Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors

EXPERT REVIEW OF NEUROTHERAPEUTICS. 2010 MAY; 10 (5): 703-710

103

1529

25463 Caudle WM, Bammler TK, Lin Y, Pan S, Zhang J

Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease

EXPERT REVIEW OF NEUROTHERAPEUTICS. 2010 JUN; 10 (6): 925-942

136

1530

25658 Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, et al.

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

NATURE REVIEWS DRUG DISCOVERY. 2010 JUL; 9 (7): 560-574

139

Date / Author / Journal

LCS

GCS

LCR

1531

25760 Ando K, Leroy K, Heraud C, Kabova A, Yilmaz Z, et al.

Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model

BIOCHEMICAL SOCIETY TRANSACTIONS. 2010 AUG; 38: 1001-1005

1532

25799 Uversky VN

Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D-2 concept

EXPERT REVIEW OF PROTEOMICS. 2010 AUG; 7 (4): 543-564

220

1533

25914 Dawson HN, Cantillana V, Jansen M, Wang H, Vitek MP, et al.

LOSS OF TAU ELICITS AXONAL DEGENERATION IN A MOUSE MODEL OF ALZHEIMER'S DISEASE

NEUROSCIENCE. 2010 AUG 11; 169 (1): 516-531

1534

25954 Hu WT, Chen-Plotkin A, Arnold SE, Grossman M, Clark CM, et al.

Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease

ACTA NEUROPATHOLOGICA. 2010 SEP; 120 (3): 385-399

1535

26322 Cowan CM, Bossing T, Page A, Shepherd D, Mudher A

Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo

ACTA NEUROPATHOLOGICA. 2010 NOV; 120 (5): 593-604

1536

26644 Hinault MP, Cuendet AFH, Mattoo RUH, Mensi M, Dietler G, et al.

Stable alpha-Synuclein Oligomers Strongly Inhibit Chaperone Activity of the Hsp70 System by Weak Interactions with J-domain Co-chaperones

JOURNAL OF BIOLOGICAL CHEMISTRY. 2010 DEC 3; 285 (49): 38173-38182

1537

1347 YETERIAN EH, PANDYA DN

THALAMIC CONNECTIONS OF THE CORTEX OF THE SUPERIOR TEMPORAL SULCUS IN THE RHESUS-MONKEY

JOURNAL OF COMPARATIVE NEUROLOGY. 1989 APR 1; 282 (1): 80-97

114

1538

1849 FLIEGNER KH, LIEM RKH

CELLULAR AND MOLECULAR-BIOLOGY OF NEURONAL INTERMEDIATE FILAMENTS

INTERNATIONAL REVIEW OF CYTOLOGY-A SURVEY OF CELL BIOLOGY. 1991; 131: 109-167

261

1539

3685 DREWES G, TRINCZEK B, ILLENBERGER S, BIERNAT J, SCHMITTULMS G, et al.

MICROTUBULE-ASSOCIATED PROTEIN MICROTUBULE AFFINITY-REGULATING KINASE (P110(MARK)) - A NOVEL PROTEIN-KINASE THAT REGULATES TAU-MICROTUBULE INTERACTIONS AND DYNAMIC INSTABILITY BY PHOSPHORYLATION AT THE ALZHEIMER-SPECIFIC SITE SERINE-262

JOURNAL OF BIOLOGICAL CHEMISTRY. 1995 MAR 31; 270 (13): 7679-7688

137

185

1540

4132 Goedert M, Spillantini MG, Hasegawa M, Jakes R, Crowther RA, et al.

Molecular dissection of the neurofibrillary lesions of Alzheimer's disease

COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY. 1996; 61: 565-573

Date / Author / Journal

LCS

GCS

LCR

1541

4258 Shea TB, Fischer I

Phosphatase inhibition in human neuroblastoma cells alters tau antigenicity and renders it incompetent to associate with exogenous microtubules

FEBS LETTERS. 1996 FEB 12; 380 (1-2): 63-67

1542

4493 Shea TB

Induction of lysosomal abnormalities and tau hyperphosphorylation in human neuroblastoma cells by colchicine and okadaic acid: Evidence that microtubule disruption contributes to Alzheimer neurodegeneration

NEUROSCIENCE RESEARCH COMMUNICATIONS. 1996 JUL-AUG; 19 (1): 27-36

1543

5180 Hoffmann R, Lee VMY, Leight S, Varga I, Otvos L

Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites

BIOCHEMISTRY. 1997 JUL 1; 36 (26): 8114-8124

100

119

1544

5218 Sergeant N, David JP, Goedert M, Jakes R, Vermersch P, et al.

Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: Demonstration of an additional 74-kDa component and age-related biochemical modifications

JOURNAL OF NEUROCHEMISTRY. 1997 AUG; 69 (2): 834-844

1545

6058 Simic G, Gnjidic M, Kostovic I

Cytoskeletal changes as an alternative view on pathogenesis of Alzheimer's disease

PERIODICUM BIOLOGORUM. 1998 JUN; 100 (2): 165-173

1546

6479 Gomez-Tortosa E, Ingraham AO, Irizarry MC, Hyman BT

Dementia with Lewy bodies

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 1998 NOV; 46 (11): 1449-1458

154

1547

6616 Iqbal K, Alonso AD, Gondal JA, Gong CX, Haque N, et al.

Inhibition of neurofibrillary degeneration: A rational and promising therapeutic target

ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 269-280

1548

7754 Jellinger KA, Stadelmann C

Mechanisms of cell death in neurodegenerative disorders

ADVANCES IN DEMENTIA RESEARCH. 2000; : 95-114

123

1549

7766 Jellinger KA, Stadelmann C

The enigma of cell death in neurodegenerative disorders

ADVANCES IN RESEARCH ON NEURODEGENERATION, VOL 8. 2000; 8: 21-36

112

1550

7834 Jellinger KA, Stadelmann C

Mechanisms of cell death in neurodegenerative disorders

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2000; (59): 95-114

123

Date / Author / Journal

LCS

GCS

LCR

1551

8333 Shibata N, Hirano A, Yamamoto T, Kato Y, Kobayashi M

Superoxide dismutase-1 mutation-related neurotoxicity in familial amyotrophic lateral sclerosis

AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS. 2000 JUN; 1 (3): 143-161

238

1552

8506 Iwai A

Properties of NACP/alpha-synuclein and its role in Alzheimer's disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2000 JUL 26; 1502 (1): 95-109

1553

8670 Kahle PJ, Neumann M, Ozmen L, Muller V, Jacobsen H, et al.

Subcellular localization of wild-type and Parkinson's disease- associated mutant alpha-synuclein in human and transgenic mouse brain

JOURNAL OF NEUROSCIENCE. 2000 SEP 1; 20 (17): 6365-6373

226

244

1554

8802 Goedert M, Satumtira S, Jakes R, Smith MJ, Kamibayashi C, et al.

Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutations

JOURNAL OF NEUROCHEMISTRY. 2000 NOV; 75 (5): 2155-2162

1555

9045 Masters CL, Beyreuther K

The natural history of Alzheimer's disease: Minding the gaps in understanding the mechanisms of neurodegeneration

NEURODEGENERATIVE DISORDERS: LOSS OF FUNCTION THROUGH GAIN OF FUNCTION. 2001; : 1-21

193

1556

9048 Price DL, Wong PC, Markowska AL, Thinakaran G, Lee MK, et al.

The value of transgenic models for the study of neurodegenerative diseases

NEURODEGENERATIVE DISORDERS: LOSS OF FUNCTION THROUGH GAIN OF FUNCTION. 2001; : 67-86

162

1557

9437 Selkoe DJ

Alzheimer's disease: Genes, proteins, and therapy

PHYSIOLOGICAL REVIEWS. 2001 APR; 81 (2): 741-766

416

2136

216

1558

10014 Schmidt ML, Zhukareva V, Perl DP, Sheridan SK, Schuck T, et al.

Spinal cord neurofibrillary pathology in Alzheimer disease and Guam parkinsonism-dementia complex

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2001 NOV; 60 (11): 1075-1086

1559

10032 Berry RW, Quinn B, Johnson N, Cochran EJ, Ghoshal N, et al.

Pathological glial tau accumulations in neurodegenerative disease: review and case report

NEUROCHEMISTRY INTERNATIONAL. 2001 NOV-DEC; 39 (5-6): 469-479

1560

10040 Chung KKK, Dawson VL, Dawson TM

The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders

TRENDS IN NEUROSCIENCES. 2001 NOV; 24 (11): S7-S14

115

Date / Author / Journal

LCS

GCS

LCR

1561

10200 Jellinger KA, Stadelmann C

Problems of programmed cell death in neurodegenerative disorders

AGING: MORPHOLOGICAL, BIOCHEMICAL, MOLECULAR AND SOCIAL ASPECTS. 2002; 27: 123-144

113

1562

10455 Mori F, Inenaga C, Yoshimoto M, Umezu H, Tanaka R, et al.

alpha-synuclein immunoreactivity in normal and neoplastic Schwann cells

ACTA NEUROPATHOLOGICA. 2002 FEB; 103 (2): 145-151

1563

10511 Zhou WB, Schaack J, Zawada WM, Freed CR

Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture

BRAIN RESEARCH. 2002 FEB 1; 926 (1-2): 42-50

1564

10804 Kruger R, Eberhardt O, Riess O, Schulz JB

Parkinson's disease: one biochemical pathway to fit all genes?

TRENDS IN MOLECULAR MEDICINE. 2002 MAY; 8 (5): 236-240

1565

11019 Teunissen CE, de Vente J, Steinbusch HWM, De Bruijn C

Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid

NEUROBIOLOGY OF AGING. 2002 JUL-AUG; 23 (4): 485-508

315

1566

11059 Meade CA, Deng YP, Fusco FR, Del Mar N, Hersch S, et al.

Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice

JOURNAL OF COMPARATIVE NEUROLOGY. 2002 JUL 29; 449 (3): 241-269

146

1567

11720 Herrmann H, Hesse M, Reichenzeller M, Aebi U, Magin TM

Functional complexity of intermediate filament cytoskeletons: From structure to assembly to gene ablation

INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 223. 2003; 223: 83-+

104

439

1568

11792 Gasser T

Overview of the genetics of parkinsonism

PARKINSON'S DISEASE. 2003; 91: 143-152

1569

11964 Wirths O, Bayer TA

alpha-synuclein, A beta and Alzheimer's disease

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2003 FEB; 27 (1): 103-108

1570

12262 Vila M, Przedborski S

Targeting programmed cell death in neurodegenerative diseases

NATURE REVIEWS NEUROSCIENCE. 2003 MAY; 4 (5): 365-375

153

163

Date / Author / Journal

LCS

GCS

LCR

1571

12270 Wong AHC, Van Tol HHM

Schizophrenia: from phenomenology to neurobiology

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2003 MAY; 27 (3): 269-306

527

1572

12597 Blennow K, Vanmechelen E

CSF markers for pathogenic processes in Alzheimer's disease: diagnostic implications and use in clinical neurochemistry

BRAIN RESEARCH BULLETIN. 2003 AUG 15; 61 (3): 235-242

1573

12729 Hogg M, Grujic ZM, Baker M, Demirci S, Guillozet AL, et al.

The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy

ACTA NEUROPATHOLOGICA. 2003 OCT; 106 (4): 323-336

1574

12736 Morris JC

Dementia update 2003

ALZHEIMER DISEASE & ASSOCIATED DISORDERS. 2003 OCT-DEC; 17 (4): 245-258

170

1575

13214 Tatebayashi Y, Sato S, Akagi T, Chui DH, Miyasaka T, et al.

Deregulation of GSK-3 beta and JNK in a mouse model of tauopathy: A kinase combination that induces Alzheimer-type tau hyperphosphorylation

MOLECULAR NEUROBIOLOGY OF ALZHEIMER DISEASE AND RELATED DISORDERS. 2004; : 62-70

1576

13622 Planel E, Miyasaka T, Launey T, Chui DH, Tanemura K, et al.

Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: Implications for Alzheimer's disease

JOURNAL OF NEUROSCIENCE. 2004 MAR 10; 24 (10): 2401-2411

1577

13650 Lindersson E, Beedholm R, Hojrup P, Moos T, Gai WP, et al.

Proteasomal inhibition by alpha-synuclein filaments and oligomers

JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 MAR 26; 279 (13): 12924-12934

110

1578

13851 Kim SH, Seo JH, Suh YH

alpha-Syrtuclein, Parkinson's disease, and Alzheimer's disease

PARKINSONISM & RELATED DISORDERS. 2004 MAY; 10: S9-S13

1579

13978 Agorogiannis EI, Agorogiannis GI, Papadimitriou A, Hadjigeorgiou GM

Protein misfolding in neurodegenerative diseases

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2004 JUN; 30 (3): 215-224

1580

14630 Lovell MA, Xiong SL, Xie CS, Davies P, Markesbery WR

Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3

JOURNAL OF ALZHEIMERS DISEASE. 2004 DEC; 6 (6): 659-671

Date / Author / Journal

LCS

GCS

LCR

1581

14644 Longhi L, Watson DJ, Saatman KE, Thompson HJ, Zhang C, et al.

Ex vivo gene therapy using targeted engraftment of NGF-expressing human NT2N neurons attenuates cognitive deficits following traumatic brain injury in mice

JOURNAL OF NEUROTRAUMA. 2004 DEC; 21 (12): 1723-1736

1582

14736 Levy YS, Gilgun-Sherki Y, Melamed E, Offen D

Therapeutic potential of neurotrophic factors in neurodegenerative diseases

BIODRUGS. 2005; 19 (2): 97-127

347

1583

14874 Iqbal K, Grundke-Iqbal I

Metabolic/signal transduction hypothesis of Alzheime's disease and other tauopathies

ACTA NEUROPATHOLOGICA. 2005 JAN; 109 (1): 25-31

1584

15030 Zhang XP, Chen YM, Jenkins LW, Kochanek PM, Clark RSB

Bench-to-bedside review: Apoptosis/programmed cell death triggered by traumatic brain injury

CRITICAL CARE. 2005 FEB; 9 (1): 66-75

123

1585

15100 Terwel D, Lasrado R, Snauwaert J, Vandeweert E, Van Haesendonck C, et al.

Changed conformation of mutant tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of tau-4R/2N transgenic mice

JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 FEB 4; 280 (5): 3963-3973

1586

15157 Yancopoulou D, Xuereb JH, Crowther RA, Hodges JR, Spillantini MG

Tau and alpha-synuclein inclusions in a case of familial frontotemporal dementia and progressive aphasia

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2005 MAR; 64 (3): 245-253

1587

15879 Blennow K

CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2005 SEP; 5 (5): 661-672

1588

15997 Liu F, Grundke-Iqbal I, Iqbal K, Gong CX

Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation

EUROPEAN JOURNAL OF NEUROSCIENCE. 2005 OCT; 22 (8): 1942-1950

106

1589

16030 Gouras GK, Almeida CG, Takahashi RH

Intraneuronal A beta accumulation and origin of plaques in Alzheimer's disease

NEUROBIOLOGY OF AGING. 2005 OCT; 26 (9): 1235-1244

116

1590

16059 Higuchi M, Zhang B, Forman MS, Yoshiyama Y, Trojanowski JQ, et al.

Axonal degeneration induced by targeted expression of mutant human tau in oligodendrocytes of transgenic mice that model glial tauopathies

JOURNAL OF NEUROSCIENCE. 2005 OCT 12; 25 (41): 9434-9443

Date / Author / Journal

LCS

GCS

LCR

1591

16121 Bronner IF, ter Meulen BC, Azmani A, Severijnen LA, Willemsen R, et al.

Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology

BRAIN. 2005 NOV; 128: 2645-2653

1592

16211 Yagi H, Kusaka E, Hongo K, Mizobata T, Kawata Y

Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins - Implications for the mechanism of transmissible conformational diseases

JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 NOV 18; 280 (46): 38609-38616

1593

16374 Ved R, Saha S, Westlund B, Perier C, Burnam L, et al.

JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 DEC 30; 280 (52): 42655-42668

1594

16377 Ulmer TS, Bax A

Comparison of structure and dynamics of micelle-bound human alpha- synuclein and Parkinson disease variants

JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 DEC 30; 280 (52): 43179-43187

1595

16498 Avila J, Santa-Maria I, Perez M, Hernandez F, Moreno F

Tau phosphorylation, aggregation, and cell toxicity

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 74539

1596

16800 Jeganathan S, von Bergen M, Brutlach H, Steinhoff HJ, Mandelkow E

Global hairpin folding of tau in solution

BIOCHEMISTRY. 2006 FEB 21; 45 (7): 2283-2293

1597

17061 Cripps D, Thomas SN, Jeng Y, Yang F, Davies P, et al.

Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation

JOURNAL OF BIOLOGICAL CHEMISTRY. 2006 APR 21; 281 (16): 10825-10838

1598

17183 Schapira AHV

Etiology of Parkinson's disease

NEUROLOGY. 2006 MAY 23; 66 (10): S10-S23

138

1599

17341 Nagatsu T, Sawada M

Cellular and molecular mechanisms of Parkinson's disease: Neurotoxins, causative genes, and inflammatory cytokines

CELLULAR AND MOLECULAR NEUROBIOLOGY. 2006 JUL-AUG; 26 (4-6): 781-802

127

1600

17431 Chau KWK, Chan WY, Shaw PC, Chan HYE

Biochemical investigation of Tau protein phosphorylation status and its solubility properties in Drosophila

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2006 JUL 21; 346 (1): 150-159

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records